omniture
Nutshell Therapeutics (Shanghai) Limited

Latest News

IND Application for NTS071, Nutshell Therapeutics' p53 Y220C Allosteric Reactivator, Received US FDA clearance

SHANGHAI, May 4, 2025 /PRNewswire/ -- On April 23, 2025, Nutshell Therapeutics ( Shanghai ) Co., ...

2025-05-04 14:48 3066